Michigan Debates Kratom and 7-OH: A Critical Juncture for Industry Compliance

Michigan Debates Kratom and 7-OH: A Critical Juncture for Industry Compliance

Lansing, MI – Michigan is currently a focal point in the ongoing national discussion surrounding kratom, with lawmakers actively debating potential bans or stringent regulations on kratom products, particularly those containing elevated levels of 7-hydroxymitragynine (7-OH). This legislative push, highlighted in a recent opinion piece by Bridge Michigan, stems from serious public health concerns regarding highly potent, lab-made 7-OH products and their potential for misuse and adverse effects.

What Happened

According to Dr. Eliza Hutchinson, a family and addiction medicine doctor, Michigan lawmakers are responding to "disturbing stories" involving young children poisoned by 7-OH products in appealing packaging, individuals in opioid recovery being drawn to these substances, and even adolescent deaths linked to seizures after 7-OH use. The core issue lies in the distinction between natural leaf kratom, which contains small amounts of 7-OH, and concentrated or synthetic 7-OH products that are significantly more potent and act on opioid receptors. A March 2026 Public Health Bulletin also underscored the rise of "synthetic kratom" and concentrated 7-OH in Michigan's unregulated market, associating them with a higher risk of overdose, severe withdrawal, and increased healthcare utilization.

While some lawmakers advocate for a complete ban, prior legislative attempts, such as House Bill 4061, proposed a Kratom Consumer Protection and Regulatory Act (KCPA) that would have introduced licensing, age restrictions (21+), and a strict cap on 7-OH content (not exceeding 2% of the total alkaloid composition).

Why It Matters to Kratom Merchants and Consumers

For kratom merchants in Michigan, the outcome of this debate carries immense implications. A full ban would necessitate an immediate cessation of all kratom-related sales and distribution, potentially devastating businesses. Even if a KCPA-like framework is adopted, it would introduce a complex web of compliance requirements, including licensing, age verification, and strict product formulation standards.

Consumers, especially those who rely on natural kratom for chronic pain management or other wellness purposes, face the prospect of losing access to products they find beneficial. The current legislative focus underscores the critical need for a clear distinction between responsibly manufactured, natural kratom products and the high-potency, potentially adulterated 7-OH enhanced products that are driving public health concerns.

Compliance Implications for High-Risk Merchants

Regardless of whether Michigan opts for a ban or regulation, the current climate demands proactive and rigorous compliance from all kratom merchants, particularly those operating in the high-risk category. The discussion highlights several key areas:

1. Certificates of Analysis (COAs): Robust, third-party COAs are no longer optional; they are paramount. Merchants must ensure their products are thoroughly tested for alkaloid profiles (mitragynine and 7-OH content), as well as for the absence of dangerous adulterants, heavy metals, and synthetic compounds. These COAs must be readily available and transparent to both consumers and regulators.
2. Lab Testing Standards: Proactive lab testing should confirm that products adhere to any proposed potency limits, such as the 2% 7-OH cap mentioned in previous legislation. This is crucial for demonstrating product safety and integrity.
3. Accurate and Transparent Labeling: Labels must clearly state the amounts of mitragynine and 7-OH, include appropriate warnings, and advise consumers to keep products out of reach of children. Misleading or candy-like packaging for high-potency products is a significant driver of current legislative concern.
4. Age Verification: Implementing strict age verification protocols to prevent sales to minors (e.g., under 21) is essential, mirroring provisions in proposed legislation.
5. Source Verification and GMP: High-risk merchants must scrutinize their supply chains, sourcing only from manufacturers who adhere to Good Manufacturing Practices (GMP) and can provide comprehensive documentation for raw materials and finished products.
6. Stay Informed: The regulatory landscape for kratom is dynamic. Merchants must actively monitor legislative developments in Michigan and other states to adapt their operations swiftly and maintain compliance.

The situation in Michigan serves as a stark reminder that the kratom industry must prioritize consumer safety and responsible practices to avoid restrictive bans. Proactive compliance, underpinned by rigorous testing and transparency, is the only path forward for the sustained viability of the kratom market.